• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; INTRODUCER, CATHETER Back to Search Results
Device Problem Difficult to Advance (2920)
Patient Problems Cardiac Tamponade (2226); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 02/03/2023
Event Type  Injury  
Manufacturer Narrative
Additional pro code dxf the device won't be returned for analysis.Upon evaluation of the failure analysis of the event reported, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported that the patient experienced a pericardial effusion with cardiac tamponade.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was), a 35mm watchman flx laa closure device & delivery system (wds) and a versacross access solution were selected to be used.It was noted that there was a trace pericardial effusion prior to the start of the procedure.The physician gained right femoral vein access and inserted the watchman fxd double curve sheath with the acucross dilator inside.Using transesophageal echocardiogram (tee), a transseptal puncture was attempted several times.However, it was noted that the sheath/dilator combo was never perpendicular to the fossa.Additionally, the sheath/dilator would ride up the fossa and was unstable every time physician attempted to deploy the needle.The physician had to push the 0.035' wire out into the right atrium (ra) again and pull down several times.Transeptal (tsp) was finally achieved (although not in an ideal location - superior and mid tsp).The fxd curve was advanced to the left atrium (la) and a pigtail inserted.An appendagram was obtained.Although trajectory was noted to be off, it was decided to attempt a flx 31mm device.The 31mm device could never be coaxial with the landing zone so another tsp was discussed.Everything was pulled to the right side and a pericardial effusion check was performed and there did not appear to be an increase in effusion from baseline.A more inferior and mid-to-posterior tsp was accomplished with a versacross system.The same fxd double curve sheath was inserted to the la.Another 31mm device was attempted but a leak was still visualized.A 35 mm device was then attempted.This device showed better tissue contact.After a strong tug test, measurements were made on tee.A contrast shot was performed and there did not appear to be any color on tee.Pass criteria was met and the device was released.A final pericardial effusion check was performed and there still did not appear to be any change to the baseline.In the post-anesthesia care unit (pacu), the patient went into tamponade and a tte showed significant pericardial effusion.The patient was brought back emergently to the cardiac catheterization lab where a physician performed a pericardial tap and roughly 500cc of blood was removed from the pericardium.The patient remains in the hospital, but it expected to make a full recovery.The physician felt like the blood was 'dark' and he feels that it was caused during the difficult transseptal at the beginning of the case.It was further reported that the patient was discharged from the hospital and is currently alive and well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS ACCESS SOLUTION
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on H4T 1 A1
CA   H4T 1A1
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17543616
MDR Text Key321133436
Report Number2124215-2023-43248
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183655
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/03/2023
Initial Date FDA Received08/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age75 YR
Patient SexMale
Patient RaceWhite
-
-